Faricimab in Treatment-Naïve nAMD: Regional UK Real-World Experience.

Pearce I, Dinah C, Downey L, Patwardhan A, Vardarinos A, Williams G.

DOI: 10.1007/s12325-026-03534-2
Published: 2026-04-18
Container: Adv Ther
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12325-026-03534-2,
  title = {Faricimab in Treatment-Naïve nAMD: Regional UK Real-World Experience.},
  author = {Pearce I and  Dinah C and  Downey L and  Patwardhan A and  Vardarinos A and  Williams G.},
  year = {2026},
  journal = {Adv Ther},
  doi = {10.1007/s12325-026-03534-2},
  url = {https://doi.org/10.1007/s12325-026-03534-2}
}

RIS

TY  - JOUR
TI  - Faricimab in Treatment-Naïve nAMD: Regional UK Real-World Experience.
AU  - Pearce I
AU  -  Dinah C
AU  -  Downey L
AU  -  Patwardhan A
AU  -  Vardarinos A
AU  -  Williams G.
PY  - 2026
JO  - Adv Ther
DO  - 10.1007/s12325-026-03534-2
UR  - https://doi.org/10.1007/s12325-026-03534-2
ER  -

APA

I, P., C, D., L, D., A, P., A, V., & G., W. (2026). Faricimab in Treatment-Naïve nAMD: Regional UK Real-World Experience.. Adv Ther. https://doi.org/10.1007/s12325-026-03534-2

Source records

europe-pmc · retrieved 2026-09-26T12:01:48.989Z